Xavier said that patients are often reluctant to quit smoking because they are fearful that they will gain weight. By adding ...

The recent decision by some US states to cover glucagon-like peptide-1 (GLP-1) agonists for obesity treatment marks a shift ...

Treating nicotine addiction with glucagon-like peptide 1 receptor agonists is associated with less weight gain compared with ...

Cigna subsidiary Evernorth Health Services will authorize prior authorizations for GLP-1 weight-loss drugs under a new ...

New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without ...

After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday.

Menopausal hormone treatment (MHT) might indirectly help with weight loss by improving sleep and redistributing abdominal fat ...

Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still ...

CheqUp is a leading provider of medically supervised weight loss programmes, offering personalised treatment plans, clinical oversight, and one-on-one coaching. CheqUp empowers individuals to take ...

In recent years, Kessler has lost considerable weight himself with the help of the new GLP-1 drugs. He describes his weight ...

GLP-1 receptor agonists are associated with improvements in restrained eating, emotional eating behavior, QOL.

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...